Skip to Content
  1. All Products
  2. Biosimilar Antibodies
  3. Gentaur Blinatumomab – Anti-CD19 / CD3E Bispecific Antibody
-
Gentaur Blinatumomab – Anti-CD19 / CD3E Bispecific Antibody

Gentaur Blinatumomab – Anti-CD19 / CD3E Bispecific Antibody

https://research.gentaur.com/web/image/product.template/472737/image_1920?unique=02640f7
(0 review)
Connects CD19 on B-cells to CD3 on T-cells, enabling T-cell–mediated cytotoxicity. A leading tool for leukemia and lymphoma research models.

1,234,567.00 € 1234567.0 EUR 1,234,567.00 € Tax Excluded

1,234,567.00 € Tax Excluded

Not Available For Sale

This combination does not exist.

Contact Us

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days

Share

Our latest content

Check out what's new in our company !

Your Dynamic Snippet will be displayed here... This message is displayed because you did not provide both a filter and a template to use.